ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

Patients Who Smoke In Treatment Do Worse Than Those Who Quit

March 25, 2011

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Varmus Confirmation On Fast Track, Nominee Outlines Goals For Next Year

November 12, 1993

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

June 18, 1993